Showing results (331-340 of 357) with videos related to
Sort By:
Pageof 36
Molecular Cancer Therapeutics|December 24, 2005
Sensitization of DNA damage-induced apoptosis by the proteasome inhibitor PS-341 is p53 dependent and involves target proteins 14-3-3sigma and survivinSusan A J Vaziri, Jason Hill, Kenichi Chikamori, et al.The Lancet. Oncology|October 26, 2007
Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II studyOlivier Rixe, Ronald M Bukowski, M Dror Michaelson, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 26, 2007
Phase I/II study of vaccination with electrofused allogeneic dendritic cells/autologous tumor-derived cells in patients with stage IV renal cell carcinomaDavid E Avigan, Baldev Vasir, Daniel J George, et al.British Journal of Cancer|January 18, 2014
Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinomaT E Hutson, R M Bukowski, B I Rini, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2008
Enhancement in specific CD8+ T cell recognition of EphA2+ tumors in vitro and in vivo after treatment with ligand agonistsAmy K Wesa, Christopher J Herrem, Maja Mandic, et al.The New England Journal of Medicine|January 12, 2007
Sunitinib versus interferon alfa in metastatic renal-cell carcinomaRobert J Motzer, Thomas E Hutson, Piotr Tomczak, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2008
Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinomaBrian I Rini, M Dror Michaelson, Jonathan E Rosenberg, et al.Leukemia|August 26, 2006
Downregulation of topoisomerase IIbeta in myeloid leukemia cell lines leads to activation of apoptosis following all-trans retinoic acid-induced differentiation/growth arrestK Chikamori, J E Hill, D R Grabowski, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2009
A phase I study of sunitinib plus bevacizumab in advanced solid tumorsBrian I Rini, Jorge A Garcia, Matthew M Cooney, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2003
MAGE-6 encodes HLA-DRbeta1*0401-presented epitopes recognized by CD4+ T cells from patients with melanoma or renal cell carcinomaTomohide Tatsumi, Lisa S Kierstead, Elena Ranieri, et al.Pageof 36